Loading...
Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer
Clinical studies have confirmed epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) used in lung cancer patients with EGFR mutations can obtain a better result, but still part of the patients with poor efficacy. EGFR mutation is highly related to female, nonsmoking and adenocar...
Saved in:
| Published in: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Ivyspring International Publisher
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134809/ https://ncbi.nlm.nih.gov/pubmed/30210620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.25679 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|